Top stocks in focus: Aurobindo Pharma, NTPC, Tata Consumer, Pfizer, SPARC

Check out the stocks that will be in focus during trade today based on recent and latest news developments.

February 24, 2021 7:30 IST

Aurobindo Pharma has entered into binding agreements to invest Rs5.382cr each in NVNR (Ramannapet I) Power Plant Private Limited and NVNR (Ramannapet /I) Power Plant Private Limited, Hyderabad based solar power generating companies, aggregating to Rs10.764cr.

Tata Consumer Products to replace GAIL India in Nifty50 Index from March 31, 2021.

Brazil approved Pfizer’s Covid vaccine for widespread use.

SPARC: USFDA has sought a new phase-3 study on cancer drug Taclantis.

NTPC has executed Share Purchase Agreements with GAIL (India) for purchase of Gail’s share (25.51%) in Ratnagiri Gas and Power Pvt. Ltd. (RGPPL) and Sale of NTPC’s share (14.82%) (on fully dilutive basis) in Konkan LNG Ltd. (KLL).

Mahindra CIE Automotive subscribed to 8,26,000 equity shares of ReNew Surya Alok Private Limited (ReNew) which constitute 31.20% of the total issued and paid-up capital of ReNew.

Sanofi India board approves re-appointment of Aditya Narayan as an Independent Director and Chairman. Board approves a final dividend of Rs125 per share and a special dividend of Rs240 per share.

Infosys Recognized as One of World’s Most Ethical Companies by Ethisphere Institute.

Heranba Industries IPO subscribed 85% on Day 1 led by stellar demand from retail investors.